Cargando…
When should surgery be used to supplement systemic therapy in metastatic renal cell cancer?
Autores principales: | Hardman, Morgan, Gabriel, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323568/ https://www.ncbi.nlm.nih.gov/pubmed/37426166 http://dx.doi.org/10.21037/jtd-23-457 |
Ejemplares similares
-
When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?
por: Rostoker, Guy
Publicado: (2018) -
Should Early Use of Chemotherapy Be Avoided in the Treatment of Metastatic Prostate Cancer?
por: Kimura, Takahiro
Publicado: (2021) -
When alternatives to screening should be the priority
por: Wald, Nicholas J, et al.
Publicado: (2022) -
When Should Oncologists Use the Words Hope and Cure?
por: Kiely, Belinda E, et al.
Publicado: (2020) -
Metastatic hormone-sensitive prostate cancer: How should it be treated?
por: López-Campos, Fernando, et al.
Publicado: (2021)